[Assignment of diagnostic approaches for bacterial sepsis].
Matsuhisa
Akio
A
Research & Development Center, Fuso Pharmaceutical Industries, Ltd.
Hoshina
Sadayori
S
D000682:Amyloid / Q000097:blood; D016470:Bacteremia / Q000175:diagnosis / Q000382:microbiology; D001431:Bacteriological Techniques / Q000379:methods; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D016207:Cytokines / Q000097:blood; D004269:DNA, Bacterial / Q000032:analysis; D019446:Endotoxemia / Q000175:diagnosis / Q000382:microbiology; D006801:Humans; D017403:In Situ Hybridization; D018836:Inflammation Mediators / Q000097:blood; D007962:Leukocytes; D025202:Molecular Diagnostic Techniques / Q000379:methods; D016133:Polymerase Chain Reaction; D018805:Sepsis / Q000175:diagnosis* / Q000382:microbiology; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000382:microbiology
D000682:Amyloid; D015415:Biomarkers; D016207:Cytokines; D004269:DNA, Bacterial; D018836:Inflammation Mediators; D002097:C-Reactive Protein